biguanides has been researched along with Leukemia L 1210 in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mihich, E | 1 |
| Jaśkowski, J | 1 |
| Witkowski, J | 1 |
| Myśliwski, A | 1 |
| Zawadzki, H | 1 |
2 other studies available for biguanides and Leukemia L 1210
| Article | Year |
|---|---|
Antileukemic action of new aromatic bisguanylhydrazone derivatives.
Topics: Animals; Antineoplastic Agents; Biguanides; Drug Synergism; Hydrazines; Leukemia L1210; Mice; Stilba | 1967 |
Effect of air ions on L 1210 cells: changes in fluorescence of membrane-bound 1,8-aniline-naphthalene-sulfonate (ANS) after in vitro exposure of cells to air ions.
Topics: Air Ionization; Anilino Naphthalenesulfonates; Animals; Biguanides; Cell Membrane; Fluorescence; Leu | 1986 |